Physician profile
Tania Serrano
NPI 1184679904
$3,297.09
in general payments reported to CMS, 2019-2025
33 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $62.02 · 2021: $539 · 2022: $461 · 2023: $768 · 2024: $690 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.81 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $835.19 | 2019-2025 | Wegovy |
| Abbvie INC. | $418.15 | 2019-2024 | Liletta, Ubrelvy, Orilissa |
| Shield Therapeutics INC | $263.72 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $210.47 | 2019-2023 | Injectafer |
| Astellas Pharma US INC | $196.15 | 2019-2025 | Veozah |
| Astrazeneca Pharmaceuticals Lp | $126.97 | 2019 | |
| Exeltis, USA INC. | $115.03 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $102.28 | 2021-2023 | Aptima, Acessa Provu System, Novasure |
| Organon LLC | $88.09 | 2021-2024 | Nexplanon |
| Axonics, INC. | $86.15 | 2024 | Axonics |
| Pfizer INC. | $85.05 | 2019-2025 | |
| Medtronic, INC. | $77.33 | 2022-2024 | Plasmablade(Tm) |
| Sumitomo Pharma America, INC. | $76.81 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $76.79 | 2019-2022 | |
| Therapeuticsmd, INC. | $75.22 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $71.67 | 2022-2025 | |
| Allergan, INC. | $47.31 | 2019 | |
| Mallinckrodt Enterprises LLC | $38.16 | 2019 | |
| Coopersurgical, INC. | $36.58 | 2019-2021 | |
| Amgen INC. | $33.27 | 2023-2024 | Evenity, Prolia |
| Applied Medical Resources Corporation | $32.17 | 2023 | |
| Biogen, INC. | $29.54 | 2025 | Zurzuvae |
| Roche Diagnostics Corporation | $25.56 | 2019 | |
| Duchesnay USA Incorporated | $24.99 | 2019 | |
| Ethicon US, LLC | $21.88 | 2023 | Enseal, Ethicon |
| Currax Pharmaceuticals LLC | $16.94 | 2023 | Onzetra Xsail, Contrave |
| Boston Scientific Corporation | $14.79 | 2023 | Solyx Sis System |
| Kvk-Tech, INC. | $14.47 | 2019 | |
| Exact Sciences Corporation | $14.36 | 2024 | Cologuard Collection Kit |
| Nalpropion Pharmaceuticals LLC | $13.20 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.77 | 2019 | |
| Becton, Dickinson and Company | $11.65 | 2022 | |
| Channel Medsystems, INC. | $5.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tania Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.